DTL
IMVT icon

Dynamic Technology Lab’s Immunovant IMVT Stock Holding History

Dynamic Technology Lab’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,670
Closed -$571K – 1159
2024
Q1 		$571K Buy
+17,670
New +$645K 0.06% 549
2023
Q2 		– Sell
-29,383
Closed -$456K – 1184
2023
Q1 		$456K Buy
+29,383
New +$510K 0.04% 663
2021
Q4 		– Sell
-17,376
Closed -$151K – 1300
2021
Q3 		$151K Sell
17,376
-2,346
-12% -$21.2K 0.02% 942
2021
Q2 		$208K Buy
+19,722
New +$275K 0.02% 928

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dynamic Technology Lab's IMVT Position: Q2 2024 in Review

Dynamic Technology Lab sold out of Immunovant (IMVT) in Q2 2024, closing a stake of 17,670 shares — an estimated $571K sold.

Dynamic Technology Lab first reported a position in IMVT in Q2 2021 and held it in 4 quarters. The position peaked at $571K in Q1 2024. 197 funds tracked by Wall St. Rank hold IMVT as of Q2 2024.

  • Dynamic Technology Lab reported no remaining Immunovant position as of Q2 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,670 Immunovant shares in Q2 2024, an estimated $571K.
  • Dynamic Technology Lab first reported a position in Immunovant in Q2 2021 and held it in 4 quarters.
  • Dynamic Technology Lab's Immunovant position peaked at $571K in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q2 2024.

Based on Dynamic Technology Lab's 13F filing for Q2 2024, filed 15 Aug 2024.